Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trevor Hawkins

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
HIV Clinical Trials|October 11, 2005
Comparison of neuropsychiatric side effects in an observational cohort of efavirenz- and protease inhibitor-treated patientsTrevor Hawkins, Cindy Geist, Ben Young, et al.
The AIDS Reader|November 10, 2007
Advances in HIV therapeutics: news from the 4th International AIDS Society ConferenceBrian A Boyle, Richard Elion, Calvin J Cohen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 13, 2005
Intracellular pharmacokinetics of tenofovir diphosphate, carbovir triphosphate, and lamivudine triphosphate in patients receiving triple-nucleoside regimensTrevor Hawkins, Wenoah Veikley, Robert L St Claire, et al.
Antimicrobial Agents and Chemotherapy|February 2, 2011
Intracellular nucleotide levels during coadministration of tenofovir disoproxil fumarate and didanosine in HIV-1-infected patientsTrevor Hawkins, Wenoah Veikley, Lucie Durand-Gasselin, et al.
HIV Clinical Trials|December 4, 2010
A pilot study of abacavir/lamivudine and raltegravir in antiretroviral-naïve HIV-1-infected patients: 48-week results of the SHIELD trialBenjamin Young, Thanes Vanig, Edwin Dejesus, et al.
AIDS (London, England)|July 1, 2011
Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adultsSherene Min, Louis Sloan, Edwin DeJesus, et al.
Antimicrobial Agents and Chemotherapy|August 20, 2008
Virologic response to lopinavir-ritonavir-based antiretroviral regimens in a multicenter international clinical cohort: comparison of genotypic interpretation scoresPhilip Grant, Eric C Wong, Richard Rode, et al.
AIDS (London, England)|August 4, 2011
Phase 2 study of cobicistat versus ritonavir each with once-daily atazanavir and fixed-dose emtricitabine/tenofovir df in the initial treatment of HIV infectionRichard Elion, Calvin Cohen, Joseph Gathe, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 29, 2006
Antiviral activity, pharmacokinetics, and dose response of the HIV-1 integrase inhibitor GS-9137 (JTK-303) in treatment-naive and treatment-experienced patientsEdwin DeJesus, Daniel Berger, Martin Markowitz, et al.
Biophysical Reviews|May 17, 2017
Contractility assessment in enzymatically isolated cardiomyocytesCarlos Bazan, David Torres Barba, Trevor Hawkins, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
HIV Clinical Trials|October 11, 2005
Comparison of neuropsychiatric side effects in an observational cohort of efavirenz- and protease inhibitor-treated patientsTrevor Hawkins, Cindy Geist, Ben Young, et al.
The AIDS Reader|November 10, 2007
Advances in HIV therapeutics: news from the 4th International AIDS Society ConferenceBrian A Boyle, Richard Elion, Calvin J Cohen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 13, 2005
Intracellular pharmacokinetics of tenofovir diphosphate, carbovir triphosphate, and lamivudine triphosphate in patients receiving triple-nucleoside regimensTrevor Hawkins, Wenoah Veikley, Robert L St Claire, et al.
Antimicrobial Agents and Chemotherapy|February 2, 2011
Intracellular nucleotide levels during coadministration of tenofovir disoproxil fumarate and didanosine in HIV-1-infected patientsTrevor Hawkins, Wenoah Veikley, Lucie Durand-Gasselin, et al.
HIV Clinical Trials|December 4, 2010
A pilot study of abacavir/lamivudine and raltegravir in antiretroviral-naïve HIV-1-infected patients: 48-week results of the SHIELD trialBenjamin Young, Thanes Vanig, Edwin Dejesus, et al.
AIDS (London, England)|July 1, 2011
Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adultsSherene Min, Louis Sloan, Edwin DeJesus, et al.
Antimicrobial Agents and Chemotherapy|August 20, 2008
Virologic response to lopinavir-ritonavir-based antiretroviral regimens in a multicenter international clinical cohort: comparison of genotypic interpretation scoresPhilip Grant, Eric C Wong, Richard Rode, et al.
AIDS (London, England)|August 4, 2011
Phase 2 study of cobicistat versus ritonavir each with once-daily atazanavir and fixed-dose emtricitabine/tenofovir df in the initial treatment of HIV infectionRichard Elion, Calvin Cohen, Joseph Gathe, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 29, 2006
Antiviral activity, pharmacokinetics, and dose response of the HIV-1 integrase inhibitor GS-9137 (JTK-303) in treatment-naive and treatment-experienced patientsEdwin DeJesus, Daniel Berger, Martin Markowitz, et al.
Biophysical Reviews|May 17, 2017
Contractility assessment in enzymatically isolated cardiomyocytesCarlos Bazan, David Torres Barba, Trevor Hawkins, et al.
Pageof 4